Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and 1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with 1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one in 1 studies

Compound Research Comparison

Studies
(3-(2,4-dimethoxybenzylidene)anabaseine)
Trials
(3-(2,4-dimethoxybenzylidene)anabaseine)
Recent Studies (post-2010)
(3-(2,4-dimethoxybenzylidene)anabaseine)
Studies
(1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one)
Trials
(1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one)
Recent Studies (post-2010) (1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one)
166881503

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chokchaisiri, R; Chuprajob, T; Lin, Y; Lu, X; Shen, X; Sornkaew, N; Suksamrarn, A; Wang, F; Wang, P; Wongkrajang, K; Yang, L; Yang, N; Zhang, G; Zhou, Z1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and 1-(4-hydroxyphenyl)-7-phenyl-(6E)-hept-6-en-3-one

ArticleYear
Discovery of diarylheptanoids that activate α7 nAchR-JAK2-STAT3 signaling in macrophages with anti-inflammatory activity in vitro and in vivo.
    Bioorganic & medicinal chemistry, 2022, 07-15, Volume: 66

    Topics: Animals; Anti-Inflammatory Agents; Diarylheptanoids; Janus Kinase 2; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Sepsis; STAT3 Transcription Factor

2022